CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −20,000 | $37.95 | $759K | 225,261 |
| 2023-03-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,360 | $38.46 | $52K | 223,901 |
| 2023-03-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,660 | $36.86 | $98K | 121,178 |
| 2023-03-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −5,000 | $37.95 | $190K | 116,178 |
| 2023-03-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −340 | $38.46 | $13K | 115,838 |
| 2023-03-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,192,515 | ||
| 2023-02-28 | Schlanger David J Executive Chairman | Exercise or conversion | +67,891 | $0.91 | $62K | 144,059 |
| 2023-02-28 | Schlanger David J Executive Chairman | Sale | −9,531 | $35.42 | $338K | 134,528 |
| 2023-02-28 | Schlanger David J Executive Chairman | Sale | −20,347 | $36.75 | $748K | 114,181 |
| 2023-02-28 | Schlanger David J Executive Chairman | Sale | −38,013 | $37.26 | $1.4M | 76,168 |
| 2023-02-28 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −67,891 | 857,228 | ||
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 255,900 |
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −4,480 | $35.39 | $159K | 251,420 |
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −12,639 | $36.82 | $465K | 238,781 |
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −14,880 | $37.29 | $555K | 223,901 |
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,120 | $35.39 | $40K | 130,718 |
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −3,160 | $36.82 | $116K | 127,558 |
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −3,720 | $37.29 | $139K | 123,838 |
| 2023-02-28 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,224,515 | ||
| 2023-02-27 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −182 | $30.57 | $6K | 58,786 |
Page 30 of 77 · 1,524 trades